Issues related to US position on intellectual property protections offered by US in international trade treaty Issues related to reform of tax code and possible timing of any such reform bill (no bill number yet) HR 2182 (Generating Antibiotic Incentives Now Act of 2011) - issues related to the development of antibiotics
S. 27 (Preserve Access to Affordable Generics Act) - Legislative proposals surrounding patent reform and intellectual property issues, including patent settlements
Issues related to US position on intellectual property protections offered by US in international trade treaty HR 3590, S 1790 (as enacted into PL 111-148 and PL 111-152) - issues related to Medicare and Medicaid reform, including possible changes to Part D rebates 
HR 2245, S 296 (Preserving Access to Life-Saving Medications Act of 2011) and related legislative proposals regarding issues surrounding potential drug shortages including notification and public reporting HR 3026 and related legislative proposals regarding establishment/implementation of pharmaceutical pedigrees and tracking/tracing of pharmaceuticals from manufacturer to consumer
HR 2674 and related legislative proposals regarding expansion of 340B health care program
HR 3590, S 1790 (as enacted into PL 111-148 and PL 111-152) - issues related to health care reform, including the CMS Innovation Center, comparative effectiveness research, and accountable care organizations
HR 2182 (Generating Antibiotic Incentives Now Act of 2011) - issues related to the development of antibiotics
HR 1254 (Synthetic Drug Control Act) - issues related to proposed controlled substance amendments
HR 3206 - issues related to FDA appointments to advisory panels and conflicts of interest
HR 1483 - issues related to drug safety, supply chain, and facility inspections HR 2190, S.1206 and related legislation proposals regarding changes/scope of Medicare Part D Rebates
HR 3590, S 1790 (as enacted into PL 111-148 and PL 111-152) - issues related to health care reform, including the CMS Innovation Center, comparative effectiveness research, and accountable care organizations
HR 3342, S 1356 - issues related to utilization of generic drugs in Medicaid program HR 1483, S.1584, S. Amdt. 769 and related legislative proposals regarding prescription drug importation and safety issues
HR 2245, S.296 (Preserving Access to Life Saving Medications Act) and related legislative proposals regarding issues surrounding potential drug shortages, including notification and public reporting HR 3026 and related legislative proposals regarding establishment/implementation of pharmaceutical pedigrees and tracking/tracing of pharmaceuticals from manufacturer to consumer
HR 1483 - issues related to drug safety, supply chain, and facility inspections
S 1946 (Foreign Manufacturers Legal Accountability Act) - issues related to registration of foreign manufacturers Discussions regarding possible clarifications to labor rules, including wage and hour issues FDA funding issues, including issues such as user fees and possible future appropriations that are likely to be incorporated into the Prescription Drug User Fee Act (PDUFA)  (no bill number yet)
TRD - Trade (domestic/foreign) TAX - Taxation/Internal Revenue Code CPT - Copyright/Patent/Trademark HCR - Health Issues MMM - Medicare/Medicaid CSP - Consumer Issues/Safety/Products LBR - Labor Issues/Antitrust/Workplace PHA - Pharmacy
136 - Centers For Medicare and Medicaid Services (CMS) 137 - Health Resources & Services Administration (HRSA) 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 136 - Centers For Medicare and Medicaid Services (CMS) 137 - Health Resources & Services Administration (HRSA) 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 136 - Centers For Medicare and Medicaid Services (CMS) 137 - Health Resources & Services Administration (HRSA) 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 136 - Centers For Medicare and Medicaid Services (CMS) 137 - Health Resources & Services Administration (HRSA) 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 136 - Centers For Medicare and Medicaid Services (CMS) 137 - Health Resources & Services Administration (HRSA) 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 136 - Centers For Medicare and Medicaid Services (CMS) 137 - Health Resources & Services Administration (HRSA) 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 136 - Centers For Medicare and Medicaid Services (CMS) 137 - Health Resources & Services Administration (HRSA) 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 136 - Centers For Medicare and Medicaid Services (CMS) 137 - Health Resources & Services Administration (HRSA) 2 - HOUSE OF REPRESENTATIVES 1 - SENATE
ASTRAZENECA PHARMACEUTICALS LP
1800 CONCORD PIKE, P.O. BOX 15437, WILMINGTON, DE, 19850, US
RICHARD BUCKLEY BRADLEY ALLEN ROSSIN RICHARD BUCKLEY DANNY LY RICHARD BUCKLEY CHRISTINE BLOOMQUIST THERESA JOLIVETTE ANDREW KAPLAN DANNY LY KIRSTEN POWELL BRADLEY ALLEN ROSSIN BELA SASTRY HEATHER STRAWN RICHARD BUCKLEY CHRISTINE BLOOMQUIST THERESA JOLIVETTE ANDREW KAPLAN DANNY LY KIRSTEN POWELL BRADLEY ALLEN ROSSIN BELA SASTRY HEATHER STRAWN RICHARD BUCKLEY CHRISTINE BLOOMQUIST THERESA JOLIVETTE ANDREW KAPLAN DANNY LY KIRSTEN POWELL BRADLEY ALLEN ROSSIN BELA SASTRY HEATHER STRAWN RICHARD BUCKLEY CHRISTINE BLOOMQUIST THERESA JOLIVETTE ANDREW KAPLAN DANNY LY BRADLEY ALLEN ROSSIN BELA SASTRY HEATHER STRAWN RICHARD BUCKLEY KIRSTEN POWELL KIRSTEN POWELL BRADLEY ALLEN ROSSIN HEATHER STRAWN RICHARD BUCKLEY ANDREW KAPLAN DANNY LY